Skip to content

Amsterdam institute for Immunology and Infectious diseases

AI&I news

  • Early HIV Treatment Only Temporarily Prevents Immune System Dysregulation
    Early HIV Treatment Only Temporarily Prevents Immune System Dysregulation Despite effective HIV medication, the immune systems of people with HIV remain dysregulated in the long term. Researchers of the Amsterdam institute for Immunology and Infectious Diseases examined whether this disruption could be prevented by starting HIV treatment immediately after infection, within just a few days. They found that the immune system functioned similarly to that of people without HIV for about six months, but over time it became disturbed again.
  • Run for Their Lives: Meet the AI&I Runners – Dilek Yusuf
    Run for Their Lives: Meet the AI&I Runners – Dilek Yusuf On March 15, AI&I researchers will lace up their running shoes for the Amstelveen Spring Marathon, raising funds for research into Post-Acute Infection Syndromes (PAIS). Every donation supports innovative projects to improve diagnosis, treatment, and quality of life for PAIS patients.
  • In the Spotlight February 2026: AI&I Prizes, Grants and Appointments
    In the Spotlight February 2026: AI&I Prizes, Grants and Appointments Recently, several prestigious prizes and grants have been awarded to our AI&I members. Please congratulate: Prof. Jan Prins, Dr. Katina Hulme, Prof. Neeltje Kootstra and Dr. Alexander Pasternak. Learn more about these accomplished individuals and their projects in the article below!

Submit your newsitem

Subscribe to our Newsletter

Sign up
Archive
Subscribe to our Newsletter

All news from Amsterdam institute for Immunology and Infectious Diseases

Early HIV Treatment Only Temporarily Prevents Immune System Dysregulation
Amsterdam UMC Immunotherapy Center: Immune Monitoring Unit and practical support
Run for Their Lives: Meet the AI&I Runners – Dilek Yusuf
In the Spotlight February 2026: AI&I Prizes, Grants and Appointments
Run for Their Lives: Meet the AI&I Runners – Valentijn Tromp
Announcement for the Joint Transnational Call 2026 - BE READY
Run for Their Lives: Meet the AI&I Runners – Roos Klungers
Dr. Joke den Haan Appointed Professor of Translational Immunology with a Focus on Cancer Vaccines
Run for Their Lives: Meet the AI&I Runners – Jan van den Bossche
No Solid Evidence Linking Vaccines to Autism Spectrum Disorder
From D25 to Nirsevimab: A Dutch Discovery that Changed Infant Health Worldwide
Decline in Annual Number of New HIV Diagnoses in the Netherlands Has Stopped
Run for Their Lives: Meet the AI&I Runners – Joppe Hovius
Vulnerabilities in Immunocompromised Patients Highlighted by Re-emerging Measles Infections in the Netherlands
Vidi Grants Awarded to Four Researchers from the Amsterdam Institute for Immunology and Infectious Diseases
Vacancy Director InFECT-TT
In the Spotlight January 2026: AI&I Prizes, Grants and Appointments
In the Spotlight December 2025: AI&I Prizes, Grants and Appointments
New Hope for Autoimmune Diseases: Telitacicept Shows Promise in Lupus Clinical Trial
PAIS IMPACT | The Amsterdam UMC Post-COVID Expertise Center: Bridging Research and Recovery
Epcoritamab offers new hope for patients with Richter Transformation
PAIS IMPACT | The Dutch Lyme Disease Expertise Center: From Research to Real-World Impact
Vote for the Amsterdam UMC Societal Impact Award 2025
In the Spotlight November 2025: AI&I Prizes, Grants and Appointments
PAIS RESEARCH | Challenges and Developments in PAIS Research with Jeroen den Dunnen
New supercomputer Helios for all of Amsterdam UMC
PAIS TOPIC 101 | With Brent Appelman
AI&I International Work Visit Grant / Advancing RNA Vaccine Research at Imperial College London
In the Spotlight October 2025: AI&I Prizes, Grants and Appointments
AI&I Collaboration Grant Facilitates In-depth Research on Rheumatic Muscle Dysfunction

Submit your newsitem